BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34527831)

  • 1. Design and development of engineered receptors for cell and tissue engineering.
    Javdan SB; Deans TL
    Curr Opin Syst Biol; 2021 Dec; 28():. PubMed ID: 34527831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming cellular functions with engineered membrane proteins.
    Arber C; Young M; Barth P
    Curr Opin Biotechnol; 2017 Oct; 47():92-101. PubMed ID: 28709113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Receptors for Sensing Soluble Molecules with Mammalian Cells.
    Scheller L
    Methods Mol Biol; 2021; 2312():15-33. PubMed ID: 34228282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Engineered Synthetic Receptor-Aptamer Pair for an Artificial Signal Transduction System.
    Liu H; Baeumler TA; Nakamura K; Okada Y; Cho S; Eguchi A; Kuroda D; Tsumoto K; Ueki R; Sando S
    ACS Nano; 2023 May; 17(10):9039-9048. PubMed ID: 37154259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering a modular double-transmembrane synthetic receptor system for customizing cellular programs.
    Zhou J; Ge Q; Wang D; Guo Q; Tao Y
    Cell Rep; 2023 Apr; 42(4):112385. PubMed ID: 37043348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering cell fate: Applying synthetic biology to cellular reprogramming.
    Wang NB; Beitz AM; Galloway KE
    Curr Opin Syst Biol; 2020 Dec; 24():18-31. PubMed ID: 36330198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of synthetic receptor systems.
    Manhas J; Edelstein HI; Leonard JN; Morsut L
    Nat Chem Biol; 2022 Mar; 18(3):244-255. PubMed ID: 35058646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular extracellular sensor architecture for engineering mammalian cell-based devices.
    Daringer NM; Dudek RM; Schwarz KA; Leonard JN
    ACS Synth Biol; 2014 Dec; 3(12):892-902. PubMed ID: 24611683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering living therapeutics with synthetic biology.
    Cubillos-Ruiz A; Guo T; Sokolovska A; Miller PF; Collins JJ; Lu TK; Lora JM
    Nat Rev Drug Discov; 2021 Dec; 20(12):941-960. PubMed ID: 34616030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development.
    Zhao N; Song Y; Xie X; Zhu Z; Duan C; Nong C; Wang H; Bao R
    Signal Transduct Target Ther; 2023 Mar; 8(1):112. PubMed ID: 36906608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Biomaterials to Modulate Notch Signaling in Tissue Engineering and Regenerative Medicine.
    Zohorsky K; Mequanint K
    Tissue Eng Part B Rev; 2021 Oct; 27(5):383-410. PubMed ID: 33040694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Engineering for Public Health: Innovations in RNA-Based Diagnostics and Therapeutics.
    Thavarajah W; Hertz LM; Bushhouse DZ; Archuleta CM; Lucks JB
    Annu Rev Chem Biomol Eng; 2021 Jun; 12():263-286. PubMed ID: 33900805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic receptors in medicine.
    Mishra S; Raval M; Singh V; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 196():303-335. PubMed ID: 36813363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering transcriptional regulation for cell-based therapies.
    Recktenwald M; Hutt E; Davis L; MacAulay J; Daringer NM; Galie PA; Staehle MM; Vega SL
    SLAS Technol; 2024 Apr; 29(2):100121. PubMed ID: 38340892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building with intent: technologies and principles for engineering mammalian cell-based therapies to sense and respond.
    Muldoon JJ; Donahue PS; Dolberg TB; Leonard JN
    Curr Opin Biomed Eng; 2017 Dec; 4():127-133. PubMed ID: 29450405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenetics of cell surface receptors: beyond genetic and pharmacological approaches.
    Miura Y; Senoo A; Doura T; Kiyonaka S
    RSC Chem Biol; 2022 Mar; 3(3):269-287. PubMed ID: 35359495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a Model Cell for Rational Tuning of GPCR Signaling.
    Shaw WM; Yamauchi H; Mead J; Gowers GF; Bell DJ; Ă–ling D; Larsson N; Wigglesworth M; Ladds G; Ellis T
    Cell; 2019 Apr; 177(3):782-796.e27. PubMed ID: 30955892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic biology for improving cell fate decisions and tissue engineering outcomes.
    Vogel AM; Persson KM; Seamons TR; Deans TL
    Emerg Top Life Sci; 2019 Nov; 3(5):631-643. PubMed ID: 33523179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.
    Weisenberger MS; Deans TL
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):599-614. PubMed ID: 29552703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Programmable Material-To-Cell Pathways Via Synthetic Notch Receptors To Spatially Control Cellular Phenotypes In Multi-Cellular Constructs.
    Garibyan M; Hoffman T; Makaske T; Do S; March AR; Cho N; Pedroncelli N; Lima RE; Soto J; Jackson B; Khademhosseini A; Li S; McCain M; Morsut L
    bioRxiv; 2023 May; ():. PubMed ID: 37293089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.